e-learning
resources
Copenhagen 2005
Wednesday 21.09.2005
A sceptical look at lung cancer screening
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
What is the evidence so far: cytology and blood tests
P. Rabbitts (Cambridge, United Kingdom)
Source:
Annual Congress 2005 - A sceptical look at lung cancer screening
Session:
A sceptical look at lung cancer screening
Session type:
Symposium
Number:
4417
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Rabbitts (Cambridge, United Kingdom). What is the evidence so far: cytology and blood tests. Annual Congress 2005 - A sceptical look at lung cancer screening
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Screening for lung cancer
Source: Eur Respir Mon; 2009: 44: 57–70
Year: 2009
Role of biomarkers for early detection of lung cancer and chemoprevention
Source: Eur Respir J 2002; 19: 1151-1158
Year: 2002
Early detection of lung cancer: role of biomarkers
Source: Eur Respir J 2003; 21: 36S-44S
Year: 2003
Screening
Source: Eur Respir J 2003; 21: 3S-15S
Year: 2003
The evidence on CT: lung cancer screening
Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice
Year: 2018
Pathology of lung cancer: histology, cytology, immunohistochemistry and molecular pathology
Source: Eur Respir Mon; 2010: 48: 272–296
Year: 2010
EU-USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer
Source: Eur Respir J 2006; 28: 1186-1189
Year: 2006
Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
Hyaluronan: A novel sputum marker for the screening and diagnosis of lung cancer patients
Source: Annual Congress 2012 - Early detection of lung cancer
Year: 2012
DR-70, A promising biomarker for the detection of lung cancer>
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021
The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection
Source: Eur Respir J 2002; 20: 464-479
Year: 2002
Is there any diagnostical significance of blood analyses in patients with lung cancer?
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005
What you have to show before you do a screening programme
Source: Annual Congress 2005 - A sceptical look at lung cancer screening
Year: 2005
Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes
Source: Eur Respir J 2010; 35: 146-151
Year: 2010
Pre-operative pulmonary evaluation of lung cancer patients: a review of the literature
Source: Eur Respir J 2009; 33: 1206-1215
Year: 2009
An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006
Airspace dimension test (ADT): A novel technique for diagnosis of the peripheral lung
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014
Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept